ICH Q12 EU Compatibility

by Q1Web AdminOct 23, 2018Blog, Life Science

The International Council for Harmonization (ICH) works to make global trade in the pharmaceutical industry easier. According to a recent article, the ICH “issued in December of 2017 a draft guidance aimed at more uniformity in rules on the quality of medicines throughout their lifecycles, particularly in the period after marketing authorization,” known as the Q12 guidelines. The guidelines, made available by the US Food and Drug Association (FDA) last May, are still in draft form and are in the process of undergoing public consultation through December 2018.

The goal of the Q12 guidelines is to cover lifecycle management issues not addressed in the ICH’s previous guidelines Q8-Q11. ICH Q12 covers the management of post-approval chemistry, manufacturing and controls (CMC) processes for both new and marketed drugs. Long term, the guidelines are predicted to reduce costs for regulators and manufacturers, as well as reduce variability and mitigate manufacturing, and quality shortages through the continual improvements on products says the FDA.

According to the Regulatory Affairs Professionals Society (RAPS), “Sections of the draft focus on the categorization of post-approval CMC changes, established conditions, post-approval change management protocols, product lifecycle management, pharmaceutical quality system and change management, the relationship between the regulatory assessment and inspection and post-approval changes for marketed products.”

However, the proposed draft appears to be incompatible with some existing European Union frameworks. “The European Commission, the European Union executive, discovered after a review of EU rules that parts of the guideline could not be implemented in the EU without changes in legislation. This is despite large sections of the guidelines already being implemented in the Union. At the Commission’s insistence but with the backing of regulatory representatives on the experts working group (EWG) drawing up the guidelines, additions were made to the guideline’s introduction about the incompatibility of the guideline with the ‘established legal framework’ in certain ICH regions,” the article states.

Ultimately, the ICH, FDA and EWG are all working toward the same overall CMC lifecycle management objectives. With the deadline for comments in the US approaching, the plan of reducing costs, while increasing post-approval change efficiency is drawing nearer.

Don’t miss the session “ICH Q12: Implications of Guidelines on Risk-Based CMC Operations” presented by Justin Aldridge, Senior Manager, Regulatory CMC at Biogen, at Q1’s 4th Annual Regulatory Affairs CMC: Chemistry, Manufacturing, and Controls Conference on October 29-30 in Philadelphia, PA. Reserve your spot today for more on ICH Q12 and other trending CMC topics.

Back to Blog

0 Comments

View Our Events

Join Our Mailing List

At Veranex, we can help you with concept through to commercialization by enabling:
• Accelerated speed to market
• Controlled development costs
• Development risk mitigation
• Market viability assessment

At every stage, we navigate our clients to realize efficiencies in cost and time with our integrated and comprehensive solutions.

Visit Sponsor Website

Since TrainingPros was founded in 1997, we have been dedicated to helping our clients find the right consultant for their projects. 25 years later, we are proud to have helped hundreds of clients complete their projects and thousands of consultants find great assignments. We continue to focus on helping our clients and consultants as well as our community as a certified women-owned, award-winning staffing company that works exclusively with Learning & Development professionals to match consultants to client projects.

Visit Sponsor Website

TELCOR is the proven leader of health care software solutions for revenue cycle management (RCM) software and services designed specifically for laboratories. TELCOR RCM, our SaaS solution, and TELCOR Revenue Cycle Services, our billing service, are designed to streamline workflow, improve collections, and provide real-time analytics. Our software and service solutions are designed for the unique challenges and requirements of laboratory specialties and the clients they serve. With full access to data, labs have complete visibility of their data and can track key performance indicators. No other vendor works as hard ensuring you get paid for the work you do.

Visit Sponsor Website

At Tipping Point Media, we pride ourselves on developing innovative, creative, and technically advanced virtual training and digital marketing solutions for the life sciences industry.

We push the limits of what's possible using Augmented and Virtual Reality to create revolutionary experiences proven to increase audience engagement and retention rates.

Our dedicated team of educators, medical experts, certified programmers, and digital renaissance innovators are committed to creating high-quality custom creations that bring your company's vision to life.

Visit Sponsor Website

VantagePoint Performance trains Salespeople to be more fluent and comfortable across different situations needing different sales approaches, and we train Sales Managers to be better coaches and team leaders, with more focus and less stress.

We’re different from the average sales training company because:

We don’t believe that one approach, one system, or one methodology is absolutely superior. All have something to offer, and the “best approach” or “best system” depends on the sales situation. This is what our applied, academic research tells us.
Our use of data science, specifically Machine Learning, helps us learn about our clients more meaningfully. We provide insights from each client’s data to help them understand what drives the success of their top-performing Salespeople and Sales Managers.
We are constantly feeding what we learn back into our training products, and we invest a bigger slice of our total energy into this innovation than the average sales training company. Our clients can access always-refreshed intellectual property and content through our training subscriptions.

Visit Sponsor Website

Policy Reporter, acquired by TrialCard in 2019, provides innovative healthcare software solutions to track payer policies in near real-time and enhances market access for the therapies patients need most. The company’s patented software-driven solutions include a suite of billing and reimbursement tools for providers and laboratories, market intelligence tools for payers, and a suite of market access solutions for life science companies. Its clients include some of the world’s largest pharmaceutical and healthcare companies.

Visit Sponsor Website